Results

Total Results: 28 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

1. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=27
   June 27, 2021 - To assess select adverse events of antidepressants in the treatment of major depressive disorder (MDD … None of the RCTs were powered or designed to capture adverse events and most RCTs studied low doses of … number of adverse events (high SOE, NNH 10) compared with placebo during treatment of the acute phase … Vortioxetine had fewer adverse events compared with duloxetine (high SOE, NNT 6 ). … events compared with placebo while adverse events were statistically similar to placebo with SSRIs (

2. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=17
   November 22, 2023 - The systematic review was supported by a Technical Expert Panel that identified key adverse events of … Studies of vaccines that used a comparator and reported the presence or absence of adverse events were … We documented observed rates and assessed the relative risks for key adverse events. … A large body of evidence is available to evaluate adverse events following vaccination. … Signals from the prior report remain unchanged for rare adverse events, which include anaphylaxis in

3. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=25
   June 27, 2021 - Adverse effects included venous thromboembolic events for tamoxifen and raloxifene; endometrial cancer … There was no difference between PrEP and placebo or no PrEP in risk of serious adverse events (12 trials … PrEP was associated with increased risk of renal adverse events (12 trials; RR, 1.43 [95% CI, 1.18 to … 0.48% to 3.43%]); most adverse events were mild and resolved with discontinuation of PrEP or with longer … PrEP is associated with increased risk of renal and gastrointestinal adverse events.

4. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=16
   July 29, 2022 - Prioritized outcomes included pain, overall function, and adverse events. … There was no effect on study withdrawals due to adverse events. … events (1 RCT, 13.9% vs. 5.7%, RR 3.12, 95% CI 1.54 to 6.33) and dizziness (1 RCT, 62.2% vs. 7.5%, RR … events (dizziness, sedation, nausea) and study withdrawal due to adverse events with high- and comparable … events and impact on use of opioids during treatment indicate that more research is needed.

5. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=33
   June 27, 2021 - Older SGAs were similar in measures of function, quality of life, mortality, and overall adverse events … Risperidone LAI and olanzapine had less withdrawal due to adverse events. … Five studies reported low rates of deaths and serious adverse events (0% to 1.25%) in patients not transported … events. … events profile of cryotherapy for the treatment of basal cell carcinoma compared to other therapeutic

6. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=53
   March 03, 2021 - READ MORE Published on March 03, 2021 Adverse Events in Women with Silicone Gel Breast Implants: A Systematic … Observational studies with sample sizes greater than 1,000 were included to assess rare adverse events … In elderly patients, adverse events included an increased risk of death (number needed to harm [NNH]= … In nonelderly adults, adverse events included weight gain (particularly with olanzapine), fatigue, sedation … events were common.

7. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=5
   October 12, 2023 - No significant differences between Tanner stages or other hormonal adverse events were reported in the … The flaxseed trial (n=32) reported no adverse events; the fish oil trial (n=42) reported gastrointestinal … events. … in Tanner staging or hormonal adverse events between statin and placebo groups. … events, no serious adverse events, or no AEs leading to withdrawals.

8. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=52
   March 07, 2023 - Adverse events: All outcomes comparing FGAs with SGAs had low or insufficient strength of evidence. … favored over olanzapine for dyslipidemia; olanzapine was favored over risperidone for prolactin-related events … For nearly all outcomes and comparisons, placebo resulted in significantly fewer adverse events than … Compared with placebo, SGAs have better symptom improvement but more adverse events.

9. Published Projects | SRDR
   srdrplus.ahrq.gov/published_projects?page=4
   October 12, 2023 - was associated with a lower likelihood of reoperation and slightly lower likelihood of any serious adverse … pain, function and likelihood of reoperation at the index level were similar, but the likelihood of an adverse … However, there were some differences in the frequency of adverse events for some comparisons.

10. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=13
    September 14, 2022 - strength of evidence that TENS may be associated with improved short-term pain and function and decreased adverse … events versus placebo; no studies evaluating this comparison were in the original report. … agents for harms including overdose, misuse, dependence, substance use disorder, withdrawals due to adverse … events, and serious adverse events (including falls, fractures, motor vehicle accidents), and specific … adverse events according to drug class?

11. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=11
    October 25, 2022 - events. … events (4 trials, N=957). … events. … events (4 trials, N=957). … Statin therapy was not associated with significantly increased risk of serious adverse events (RR 0.97

12. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=51
    June 23, 2021 - Differences exist in the incidence of specific adverse events and the onset of action. … Differences with respect to onset of action and adverse events may be taken into consideration for the … Interventions from all categories had evidence of net benefit and no serious adverse consequences.

13. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=46
    June 23, 2021 - Compared with no intravesical therapy, BCG was associated with a higher rate of local and systemic adverse … events (granulomatous cystitis or irritative symptoms in 27% to 84% of patients, macroscopic hematuria … Compared with MMC, BCG was also associated with an increased risk of local adverse events and fever ( … associated with decreased risk of bladder cancer progression, but is associated with a high rate of adverse … events.

14. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=43
    June 27, 2021 - To assess the efficacy, comparative effectiveness, and adverse effects of drugs newly used (last 10 years … Tadalafil improved LUTS more than placebo but had more adverse effects. … Few studies reported adverse events; when reported, few events were noted. Conclusions. … We found insufficient evidence on adverse effects of these interventions. … Evidence on adverse effects from RCT data was generally insufficient or low strength.

15. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=19
    June 27, 2021 - in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse … events, and long-term use of opioids. … Antiviral therapy was associated with higher risk of withdrawal due to adverse events versus placebo … events (high strength of the body of evidence [SOE]). … events (moderate SOE).

16. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=26
    June 27, 2021 - points on a 0 to 10 pain scale, time to analgesia of 5 minutes, 10% absolute risk difference for any adverse … Opioids may cause fewer adverse events than ketamine (low SOE), primarily administered intranasally ( … Opioids cause more dizziness (moderate SOE) and may cause more adverse events than APAP (low SOE), both … Opioids may cause more adverse events and more drowsiness than NSAIDs (low SOE), administered primarily

17. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=32
    June 27, 2021 - Summary of adverse events. This is an update of a 2012 review done by the Minnesota EPC. … with less periprocedural pain, faster improvement in symptom scores and quality of life, and fewer adverse … events.

18. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=24
    October 31, 2022 - are an effective prevention intervention for women at increased risk, although medications also cause adverse … Risks for thromboembolic events and endometrial cancer with tamoxifen were higher for older compared … All medications caused adverse effects, such as vasomotor or musculoskeletal symptoms, that varied by … anastrozole reduce invasive breast cancer in women without preexisting breast cancer, but also cause adverse … Tamoxifen and raloxifene increase thromboembolic events and tamoxifen increases endometrial cancer and

19. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=9
    January 17, 2023 - , 3) What are the adverse effects of COPD treatments in this population? … None of the included treatment trials that reported adverse effects found significant harms. … Absolute risk reductions in major CVD events in the trials ranged from 0.08 to 2.5 percent. … percent for extracranial bleeding events. … update evidence on the effectiveness of hormone therapy in reducing risk of chronic conditions, its adverse

20. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=22
    June 27, 2021 - specific types of chronic pain, considering the effects of on pain, function, quality of life, and adverse … events.